Skip to main content

Table 2 Helicobacter pylori eradication rate

From: Efficacy of two-week therapy with doxycycline-based quadruple regimen versus levofloxacin concomitant regimen for helicobacter pylori infection: a prospective single-center randomized controlled trial

 

levofloxacin concomitant regimen

doxycycline-based quadruple regimen

Odds Ratio (95% CI)

P-Value

ITT

82.1%

76.9%

1.371 (0.454,4.146)

0.78

PPA

82.1%

78.9%

1.219 (0.394,3.774)

0.78

  1. CI confidence interval, ITT intention to treat analysis, PPA per-protocol analysis
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us